Literature DB >> 10615067

Increased expression of functionally active membrane-associated tumor necrosis factor in acute respiratory distress syndrome.

L Armstrong1, D R Thickett, S J Christie, H Kendall, A B Millar.   

Abstract

Membrane-associated tumor necrosis factor (mTNF) has recently been shown to induce inflammatory cellular responses previously attributed to the soluble form. The present study measures for the first time the expression and function of mTNF on the surface of alveolar macrophages (AMs) to determine whether it is associated with the development of acute respiratory distress syndrome (ARDS). TNF expression was determined by flow cytometry, and the function of mTNF on the surface of AMs was determined by an in vitro cytotoxicity assay. Tumor necrosis factor (TNF)-alpha bioactivity was measured by bioassay. Soluble TNF receptor (TNFR) protein and messenger RNA (mRNA) expression were measured by enzyme-linked immunosorbent assay and reverse transcriptase/polymerase chain reaction, respectively. Increased detection of mTNF was observed on the surface of AMs derived from subjects with ARDS (mean percentage increase in fluorescence 22.30 +/- 3.50% for subjects with ARDS compared with 7.09 +/- 1.70% for At Risk subjects [P < 0.003]). mTNF cytotoxicity in the bioassay positively correlated with the mTNF expression determined by flow cytometry (r(2) = 0.97). Although there was increased mTNF expression and cytotoxic function in ARDS, there was no significant increase in soluble TNF expression in the bronchoalveolar lavage fluid or the AM supernatants. Lower levels of CD120b-soluble TNFR were detected in the AM supernatants derived from subjects with ARDS compared with At Risk (mean 0.264 +/- 0.058 versus 0.593 +/- 0.143 ng/ml, respectively [P < 0.05]). By contrast, there was increased CD120b mRNA expression in AMs derived from subjects with ARDS (P < 0.03), suggesting that increased surface expression of this receptor may be important in mediating the signal of mTNF. These data demonstrate for the first time the presence of functionally active mTNF on the surface of AMs in ARDS and highlight a potential mechanism for TNF-mediated lung injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10615067     DOI: 10.1165/ajrcmb.22.1.3728

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  12 in total

1.  Sources of alveolar soluble TNF receptors during acute lung injury of different etiologies.

Authors:  Anthony D Dorr; Michael R Wilson; Kenji Wakabayashi; Alicia C Waite; Brijesh V Patel; Nico van Rooijen; Kieran P O'Dea; Masao Takata
Journal:  J Appl Physiol (1985)       Date:  2011-04-21

2.  Genomic and Genetic Approaches to Deciphering Acute Respiratory Distress Syndrome Risk and Mortality.

Authors:  Heather Lynn; Xiaoguang Sun; Nancy Casanova; Manuel Gonzales-Garay; Christian Bime; Joe G N Garcia
Journal:  Antioxid Redox Signal       Date:  2019-06-18       Impact factor: 8.401

3.  Pharmacological profile of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in models of airway inflammation.

Authors:  Alexandre Trifilieff; Christoph Walker; Thomas Keller; Georg Kottirsch; Ulf Neumann
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

4.  Tumour necrosis factor-alpha processing in interstitial lung disease: a potential role for exogenous proteinase-3.

Authors:  L Armstrong; S I H Godinho; K M Uppington; H A Whittington; A B Millar
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

Review 5.  Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.

Authors:  Takahiko Horiuchi; Hiroki Mitoma; Shin-ichi Harashima; Hiroshi Tsukamoto; Terufumi Shimoda
Journal:  Rheumatology (Oxford)       Date:  2010-03-01       Impact factor: 7.580

6.  HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor alpha in spinal cord microglia.

Authors:  Z Zhou; X Peng; S Hao; D J Fink; M Mata
Journal:  Gene Ther       Date:  2007-11-22       Impact factor: 5.250

7.  Parenchymal cell TNF receptors contribute to inflammatory cell recruitment and respiratory failure in Pneumocystis carinii-induced pneumonia.

Authors:  Gloria S Pryhuber; Heidie L Huyck; Samir Bhagwat; Michael A O'Reilly; Jacob N Finkelstein; Francis Gigliotti; Terry W Wright
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

Review 8.  Experimental models and emerging hypotheses for acute lung injury.

Authors:  Thomas R Martin; Gustavo Matute-Bello
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

Review 9.  Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis.

Authors:  Heejin Lim; Sang Hyung Lee; Hyun Tae Lee; Jee Un Lee; Ji Young Son; Woori Shin; Yong-Seok Heo
Journal:  Int J Mol Sci       Date:  2018-03-07       Impact factor: 5.923

10.  The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome.

Authors:  Panagiotis Agouridakis; Despina Kyriakou; Michael G Alexandrakis; Athanasios Prekates; Kostas Perisinakis; Nikolaos Karkavitsas; Demosthenes Bouros
Journal:  Respir Res       Date:  2002-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.